These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Design, synthesis and preliminary bioactivity studies of 1,3,4-thiadiazole hydroxamic acid derivatives as novel histone deacetylase inhibitors. Guan P, Sun F, Hou X, Wang F, Yi F, Xu W, Fang H. Bioorg Med Chem; 2012 Jun 15; 20(12):3865-72. PubMed ID: 22579621 [Abstract] [Full Text] [Related]
3. Synthesis and biological characterization of amidopropenyl hydroxamates as HDAC inhibitors. Thaler F, Varasi M, Colombo A, Boggio R, Munari D, Regalia N, Rozio MG, Reali V, Resconi AE, Mai A, Gagliardi S, Dondio G, Minucci S, Mercurio C. ChemMedChem; 2010 Aug 02; 5(8):1359-72. PubMed ID: 20572281 [Abstract] [Full Text] [Related]
4. Influence of the adamantyl moiety on the activity of biphenylacrylohydroxamic acid-based HDAC inhibitors. Cincinelli R, Musso L, Giannini G, Zuco V, De Cesare M, Zunino F, Dallavalle S. Eur J Med Chem; 2014 May 22; 79():251-9. PubMed ID: 24742384 [Abstract] [Full Text] [Related]
5. Synthesis, biological characterization and molecular modeling insights of spirochromanes as potent HDAC inhibitors. Thaler F, Moretti L, Amici R, Abate A, Colombo A, Carenzi G, Fulco MC, Boggio R, Dondio G, Gagliardi S, Minucci S, Sartori L, Varasi M, Mercurio C. Eur J Med Chem; 2016 Jan 27; 108():53-67. PubMed ID: 26629860 [Abstract] [Full Text] [Related]
6. Amide-based derivatives of β-alanine hydroxamic acid as histone deacetylase inhibitors: attenuation of potency through resonance effects. Liao V, Liu T, Codd R. Bioorg Med Chem Lett; 2012 Oct 01; 22(19):6200-4. PubMed ID: 22932316 [Abstract] [Full Text] [Related]
9. Pyrimidinedione-mediated selective histone deacetylase 6 inhibitors with antitumor activity in colorectal cancer HCT116 cells. Liu YM, Lee HY, Lai MJ, Pan SL, Huang HL, Kuo FC, Chen MC, Liou JP. Org Biomol Chem; 2015 Oct 28; 13(40):10226-35. PubMed ID: 26309122 [Abstract] [Full Text] [Related]
17. Alkyl piperidine and piperazine hydroxamic acids as HDAC inhibitors. Rossi C, Porcelloni M, D'Andrea P, Fincham CI, Ettorre A, Mauro S, Squarcia A, Bigioni M, Parlani M, Nardelli F, Binaschi M, Maggi CA, Fattori D. Bioorg Med Chem Lett; 2011 Apr 15; 21(8):2305-8. PubMed ID: 21420859 [Abstract] [Full Text] [Related]